Cargando…

Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”

Detalles Bibliográficos
Autores principales:	Mandt, Stephen R., Gaitonde, Puneet, Ajavon-Hartmann, Antoinette, Klem, Christian, Chan, Anthony, Bastien, Arnaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134427/ https://www.ncbi.nlm.nih.gov/pubmed/35603638 http://dx.doi.org/10.1177/10760296221078841

Ejemplares similares

Critical Analysis of Apixaban Dose Adjustment Criteria
por: Vu, Anh, et al.
Publicado: (2021)

Cabozantinib and apixaban: an hitherto unreported interaction
por: Santini, Daniele, et al.
Publicado: (2019)

The contribution of apixaban renal clearance to total clearance
por: Frost, Charles, et al.
Publicado: (2015)

ADPKD, COVID-19, and Apixaban: The Treacherous Intracystic Bleeding − A Letter on Apixaban Causing Hepatic Cystic Bleeding by Shehi et al.
por: Sergi, Consolato M.
Publicado: (2022)

Apixaban returned to CVS Caremark formulary after outcry
por: Waldron, Beth
Publicado: (2022)

Cancer associated phlegmasia cerulea dolens successfully treated with apixaban
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2018)

The Problem With Predictions: A Cautionary Tale of Empirically Adjusting Apixaban Dosing With Carbamazepine
por: Chadha, Ayush, et al.
Publicado: (2022)

Series with complete resolution of left atrial appendage thrombi with apixaban in elderly patients
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Successful Revascularization of Acute Middle Cerebral Artery Occlusion by Intravenous Thrombolysis While on Apixaban
por: Nambiar, Vivek K., et al.
Publicado: (2017)

DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban)
por: Ryu, Rachel
Publicado: (2022)

Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitations
por: Alves, Geisa Cristina da Silva, et al.
Publicado: (2020)

Drugs available through the Farmácia Dose Certa program and Beers criteria: a further analysis
por: Oliveira, Márcio Galvão, et al.
Publicado: (2012)

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

On the authorship criteria
por: Rakhshan, Vahid
Publicado: (2014)

Diagnostic Criteria during SARS Outbreak in Hong Kong
por: Chan, Louis Y., et al.
Publicado: (2004)

Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
por: Robertsen, Ida, et al.
Publicado: (2019)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016)

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement
por: Kojima, Minoru, et al.
Publicado: (2020)

Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management
por: Talamo, Laura, et al.
Publicado: (2017)

The Maze of Vasodilator Response Criteria
por: Douwes, J. Menno, et al.
Publicado: (2010)

Plagiarism: Intention and diagnostic criteria
por: Shashok, Karen
Publicado: (2012)

Sepsis: Mr. Machado's criteria
por: Gomes, José Andrade
Publicado: (2017)

“Farmácia Dose Certa” program and Beers-Fick criteria: general versus specific analysis
por: Lucchetti, Giancarlo, et al.
Publicado: (2012)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Malfunction of adjustable pressure limiting valve
por: Chaturvedi, Apoorv Upendra, et al.
Publicado: (2017)

Problems in the Japanese criteria for metabolic syndrome
por: Oda, Eiji
Publicado: (2011)

Defining the criteria for identifying constitutional epimutations
por: Sloane, Mathew A., et al.
Publicado: (2016)

Reproducibility of Diagnostic Criteria for Ventricular Neurocysticercosis
por: Fleury, Agnes, et al.
Publicado: (2017)

Response to: Abdominal CT: a radiologist-driven adjustment of the dose of iodinated contrast agent approaches a calculation per lean body weight
por: Peet, Kris A.
Publicado: (2020)

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Critical errors found during metered dose inhaler technique demonstration by Pharmacists
por: Adnan, Muhammad, et al.
Publicado: (2016)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply
por: Park, Dong Won, et al.
Publicado: (2010)

Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018: Revision of Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2011
por: Kawa, Shigeyuki, et al.
Publicado: (2020)

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
por: Frost, Charles E., et al.
Publicado: (2015)

Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Preparation of Apixaban Solid Dispersion for the Enhancement of Apixaban Solubility and Permeability
por: Lee, Juseung, et al.
Publicado: (2023)

Over-Adjustment Bias by Controlling for Overall Health
por: Assari, Shervin
Publicado: (2013)

Reply to Letter to Editor: Abdominal CT: a radiologist-driven adjustment of the dose of iodinated contrast agent approaches a calculation per lean body weight
por: Zanardo, Moreno, et al.
Publicado: (2020)

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
por: Peyro-Saint-Paul, Laure, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nlsgpqj0cicbrhhaopc725l0oe